Autoimmunity BioSolutions Raises $1.0M

Dolfin

Dolfin Partners is a specialty finance company providing long-term lease financing for capital expenditures associated with commercial space. The Dolfin Lease is a private, bilateral financing instrument priced on the tenant's credit, not the real estate. Fixed rate. Fully amortizing. Unsecured. Structured from 10 to 20 years to match the useful life of the asset. No collateral pledge. No balloon payment. No refinancing risk. For corporate tenants: Your build-out is a long-term asset. Your financing should be too. If your company is investment-grade or near-IG, you likely qualify. Dolfin finances 100% of your tenant improvements, equipment, and soft costs during construction — converting your capital expenditure into a single, fixed-rate lease at completion. No upfront equity required. No revolver draw. No asset pledge. For improvements already funded, Dolfin reimburses 100% of your sunk costs at close, freeing that capital to be redeployed into your core business. For landlords: Replace your TI equity. Dolfin holds the lease obligation — you hold the space. Non-recourse, no property liens or senior lender approval. New York, NY

Hint Inc.

Hint, is a San Francisco-based beverage company that was founded in 2005 and is best known for its delicious unsweetened flavored water. Hint is on a mission to help people everywhere fall in love with water. The idea behind our company is simple: pure water, nature's original refreshment, accented with fruit essence. No sugar, no diet sweeteners. EVER. Hint is one of the fastest-growing flavored water in the United States. The brand has received numerous accolades, including Best Flavored Water (from Health, Men’s Health, and SELF magazines). Headquartered in San Francisco, Hint is looking for driven collaborative individuals to help us achieve our mission of healthier lifestyles for all. Hint is an equal opportunity employer. We are committed to creating an inclusive environment for all employees.

Secludy AI

Privacy-guaranteed synthetic data generation for training AI models

BranchLab

BranchLab is the AI platform for biopharma commercialization. Biopharma companies and their marketing agencies in-house BranchLab’s platform to model high-value patient and provider populations, activate omnichannel, and measure real-world outcomes without using personal health data. The BranchLab platform is designed to streamline how therapies are brought to market in the AI era

WiseCost, Inc.

WiseCost helps government contractors stay DCAA compliant with less effort and greater accuracy. From automated time tracking and job costing to indirect rate calculations and audit-ready reports, we provide everything small and mid-sized GovCons need to run a fully compliant accounting system. Built for teams that rely on QuickBooks Online, WiseCost eliminates spreadsheets, manual adjustments, and audit risks — giving contractors a powerful, intuitive platform to manage compliance and profitability in one place.